New mechanism in the modulation of carbon tetrachloride hepatotoxicity in rats using different natural antioxidants

Nouf Mohamed Al-Rasheed1, Laila Mohamed Fadda1, Hanaa Mahmoud Ali2,3

  • 1a Department of Pharmacology , Faculty of Pharmacy, King Saud University , Riyadh , Kingdom of Saudi Arabia .

Insights

Silymarin, vitamin E, and curcumin protect the liver from carbon tetrachloride (CCl4) damage by reducing apoptotic factors and increasing antioxidant Nrf2 expression. This combination shows potent hepatoprotective effects.

Area of Science:

  • Hepatology
  • Biochemistry
  • Molecular Biology

Background:

  • Transforming growth factor-β (TGF-β1) signaling pathways, including Smads, AKT, MAPK, and STAT3, are implicated in apoptosis and fibrosis.
  • NF-E2-related factor-2 (Nrf2) is a key regulator of antioxidant and detoxification genes in the liver.
  • Carbon tetrachloride (CCl4) is a known hepatotoxin that induces liver damage through oxidative stress and apoptosis.

Purpose of the Study:

  • To investigate the modulatory effects of silymarin, alone or in combination with vitamin E and/or curcumin, on CCl4-induced liver injury.
  • To assess the impact of these treatments on key apoptotic and fibrogenic signaling pathways (MAPK, STAT3, AKT, Smad-2, TGF-β) and the antioxidant factor Nrf2.

Main Methods:

  • Rats were administered CCl4 to induce liver damage.
  • Treatment groups received silymarin alone, vitamin E alone, curcumin alone, or combinations thereof.
  • Hepatic protein expressions of MAPK, STAT3, AKT, Smad-2, TGF-β, and Nrf2 were analyzed.

Main Results:

  • CCl4 administration significantly increased serum ALT levels and hepatic expressions of MAPK, STAT3, AKT, Smad-2, and TGF-β.
  • Silymarin alone downregulated these pro-apoptotic and fibrogenic factors.
  • Combinations of silymarin with vitamin E and/or curcumin demonstrated the most significant protective effects, further downregulating apoptotic markers and increasing Nrf2 expression.

Conclusions:

  • CCl4 induces liver damage by upregulating apoptotic and fibrogenic factors.
  • Silymarin, especially when combined with vitamin E and/or curcumin, exhibits significant hepatoprotective effects by modulating these pathways.
  • The combination therapy potentiates silymarin's anti-apoptotic action, suggesting its potential as a hepatoprotective agent against various hepatotoxins.

Related Concept Videos